
TY  - JOUR
TI  - Abstract of 30th Regional Congress of the ISBT
JO  - Vox Sanguinis
JA  - Vox Sang
VL  - 114
IS  - S2
SN  - 0042-9007
UR  - https://doi.org/10.1111/vox.12847
DO  - doi:10.1111/vox.12847
SP  - 5
EP  - 135
PY  - 2019
ER  - 

TY  - JOUR
TI  - 2014 Annual Meeting of the American Society for Bone and Mineral Research Houston, TX September 12–15, 2014
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 29
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.2476
DO  - doi:10.1002/jbmr.2476
SP  - S1
EP  - S1
PY  - 2014
AB  - ABSTRACT Searchable abstracts may be found at http://www.asbmr.org/education/abstracts
ER  - 

TY  - JOUR
TI  - Mini Oral Sessions
JO  - Transplant International
VL  - 24
IS  - s2
SN  - 0934-0874
UR  - https://doi.org/10.1111/j.1432-2277.2011.01349.x
DO  - doi:10.1111/j.1432-2277.2011.01349.x
SP  - 105
EP  - 130
PY  - 2011
ER  - 

TY  - JOUR
TI  - Poster Presentations - Poster Session 1: Sunday, 30 August 2009 - Monday, 31 August 2009
JO  - Transplant International
VL  - 22
IS  - s2
SN  - 0934-0874
UR  - https://doi.org/10.1111/j.1432-2277.2009.00958.x
DO  - doi:10.1111/j.1432-2277.2009.00958.x
SP  - 95
EP  - 222
PY  - 2009
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - British Journal of Haematology
VL  - 157
IS  - s1
SN  - 0007-1048
UR  - https://doi.org/10.1111/j.1365-2141.2012.09071.x
DO  - doi:10.1111/j.1365-2141.2012.09071.x
SP  - 1
EP  - 88
PY  - 2012
ER  - 

TY  - JOUR
TI  - SIOP 2013 Scientific Programme + Index
JO  - Pediatric Blood & Cancer
JA  - Pediatr Blood Cancer
VL  - 60
IS  - S3
SN  - 1545-5009
UR  - https://doi.org/10.1002/pbc.24719
DO  - doi:10.1002/pbc.24719
SP  - S1
EP  - S264
PY  - 2013
ER  - 

TY  - JOUR
AU  - Bennett, Clare L.
AU  - Misslitz, Ana
AU  - Colledge, Lisa
AU  - Aebischer, Toni
AU  - Blackburn, C. Clare
TI  - Silent infection of bone marrow-derived dendritic cells by Leishmania mexicana amastigotes
JO  - European Journal of Immunology
JA  - Eur. J. Immunol.
VL  - 31
IS  - 3
SN  - 0014-2980
UR  - https://doi.org/10.1002/1521-4141(200103)31:3<876::AID-IMMU876>3.0.CO;2-I
DO  - doi:10.1002/1521-4141(200103)31:3<876::AID-IMMU876>3.0.CO;2-I
SP  - 876
EP  - 883
KW  - Dendritic cell
KW  - Leishmania
KW  - Activation signal
KW  - Green fluorescent protein
PY  - 2001
AB  - Abstract Resolution of infection by Leishmania sp. is critically dependent on activation of CD4+ T helper cells. Naive CD4+ T helper cells are primed by dendritic cells which have responded to an activation signal in the periphery. However, the role of Leishmania-infected dendritic cells in the activation of an anti-Leishmania immune response has not been comprehensively addressed. Using the highly controlled model system of bone marrow-derived dendritic cell infection by Leishmania mexicana cultured in vitro, we show that uptake of L.?mexicana parasites does not result in activation of immature dendritic cells or secretion of IL-12. Incubation with L.?mexicana promastigotes results in the activation of a small percentage of dendritic cells which do not appear to contain whole parasites. Activation of dendritic cells is not suppressed by infection, since infected cells can be fully activated on addition of activating stimuli. Therefore, uptake of intact Leishmania mexicana parasites is not sufficient to activate dendritic cells in vitro. We propose that these data provide a basis for interpreting the interactions between dendritic cells and all Leishmania sp.
ER  - 

TY  - JOUR
TI  - APOS 1st annual conference abstracts
JO  - Psycho-Oncology
JA  - Psycho‐Oncology
VL  - 13
IS  - S1
SN  - 1057-9249
UR  - https://doi.org/10.1002/pon.778
DO  - doi:10.1002/pon.778
SP  - S1
EP  - S75
PY  - 2004
ER  - 

TY  - JOUR
AU  - Freeman Jr, R. B.
AU  - Steffick, D. E.
AU  - Guidinger, M. K.
AU  - Farmer, D. G.
AU  - Berg, C. L.
AU  - Merion, R. M.
TI  - Liver and Intestine Transplantation in the United States, 1997–2006
JO  - American Journal of Transplantation
VL  - 8
IS  - 4p2
SN  - 1600-6135
UR  - https://doi.org/10.1111/j.1600-6143.2008.02174.x
DO  - doi:10.1111/j.1600-6143.2008.02174.x
SP  - 958
EP  - 976
KW  - Deceased donors
KW  - donation after cardiac death (DCD)
KW  - hepatocellular carcinoma (HCC)
KW  - intestine
KW  - liver waiting list
KW  - living donors
KW  - MELD
KW  - organ donation
KW  - PELD
KW  - SRTR
KW  - waiting list
PY  - 2008
AB  - Liver transplantation in 2006 generally resembled previous years, with fewer candidates waiting for deceased donor liver transplants (DDLT), continuing a trend initiated with the implementation of the model for end-stage liver disease (MELD). Candidate age distribution continued to skew toward older ages with fewer children listed in 2006 than in any prior year. Total transplants increased due to more DDLT with slightly fewer living donor liver transplants (LDLT). Waiting list deaths and time to transplant continued to improve. In 2006, there also were fewer DDLT for patients with MELD <15, fewer pediatric Status 1A/B transplants and more transplants from donation after cardiac death (DCD) donors. Adjusted patient and graft survival rates were similar for LDLT and DDLT. This article also contains in-depth analyses of transplantation for hepatocellular carcinoma (HCC). Recipients with HCC had lower adjusted 3-year posttransplant survival than recipients without HCC. HCC recipients who received pretransplant ablative treatments had superior adjusted 3-year posttransplant survival compared to HCC recipients who did not. Intestinal transplantation continued to slowly increase with the largest number of candidates on the waiting list since 1997. Survival rates have increased over time. Small children waiting for intestine grafts continue to have the highest waiting list mortality.
ER  - 

TY  - JOUR
TI  - Posters
JO  - Transplant International
JA  - Transpl Int
VL  - 30
IS  - S2
SN  - 0934-0874
UR  - https://doi.org/10.1111/tri.13053
DO  - doi:10.1111/tri.13053
SP  - 390
EP  - 576
PY  - 2017
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - British Journal of Haematology
JA  - Br J Haematol
VL  - 173
IS  - S1
SN  - 0007-1048
UR  - https://doi.org/10.1111/bjh.14019
DO  - doi:10.1111/bjh.14019
SP  - 5
EP  - 178
PY  - 2016
ER  - 

TY  - JOUR
TI  - Tuesday, 26 July 2011
JO  - Journal of Thrombosis and Haemostasis
VL  - 9
IS  - s2
SN  - 1538-7933
UR  - https://doi.org/10.1111/j.1538-7836.2011.04380_2.x
DO  - doi:10.1111/j.1538-7836.2011.04380_2.x
SP  - 251
EP  - 498
PY  - 2011
ER  - 

TY  - JOUR
AU  - Kim, Dae Y.
AU  - Moon, Jang
AU  - Island, Eddie R.
AU  - Tekin, Akin
AU  - Ganz, Susan
AU  - Levi, David
AU  - Selvaggi, Gennaro
AU  - Nishida, Seigo
AU  - Tzakis, Andreas G.
TI  - Liver transplantation using elderly donors: a risk factor analysis
JO  - Clinical Transplantation
VL  - 25
IS  - 2
SN  - 0902-0063
UR  - https://doi.org/10.1111/j.1399-0012.2010.01222.x
DO  - doi:10.1111/j.1399-0012.2010.01222.x
SP  - 270
EP  - 276
KW  - elderly donor
KW  - expanded criteria
KW  - liver transplantation
KW  - risk factor
KW  - survival
PY  - 2011
AB  - Kim DY, Moon J, Island ER, Tekin A, Ganz S, Levi D, Selvaggi G, Nishida S, Tzakis AG. Liver transplantation using elderly donors: a risk factor analysis. ?Clin Transplant 2011: 25: 270?276. ? 2010 John Wiley & Sons A/S. Abstract:? Survival after liver transplantation is negatively impacted by use of elderly deceased donors, but excluding them would increase waiting times and waiting list mortality. We reviewed our experience with liver transplantation (LT) utilizing livers from deceased donors 65?yr of age and older to identify those factors that impact graft survival. All adult patients (≥18?yr old) who underwent primary LT using deceased donor livers from donors aged ≥65?yr between February 1995 and November 2003 were included. With multivariate analysis we found four unfavorable characteristics significantly associated with higher post-transplant graft failure rate. These characteristics are hepatitis C as an etiology of liver disease, Model for End-Stage Liver Disease score >20, serum glucose level of donor >200?mg/dL at the time of liver recovery, and skin incision to aortic cross-clamp time >40?minutes in the donor surgery. The five-yr estimated graft survival rates having 0, 1, 2, 3, and 4 unfavorable characteristics were 100%, 82.0%, 81.7%, 39.3%, and 25.0%, respectively (p?<?0.05). Our data demonstrated good graft survival can be achieved in LT using elderly donor liver allografts with appropriate patient selection, donor blood glucose management and efficient liver recovery with minimal manipulation of the liver during donor surgery.
ER  - 

TY  - JOUR
AU  - Taub, Dennis D.
TI  - Cytokine, Growth Factor, and Chemokine Ligand Database
JO  - Current Protocols in Immunology
JA  - Current Protocols in Immunology
VL  - 61
IS  - 1
SN  - 1934-3671
UR  - https://doi.org/10.1002/0471142735.im0629s61
DO  - doi:10.1002/0471142735.im0629s61
SP  - 6.29.1
EP  - 6.29.89
KW  - chemokines
KW  - cytokines
KW  - interleukins
KW  - growth factor
PY  - 2004
AB  - Abstract Cytokines, chemokines, and growth factors are soluble proteins produced by leukocytes and other cell types, which act as chemical communicators between cells and tissues within the body. These proteins mediate a number of functions, ranging from effects on cell growth, differentiation, survival, and a number of effector activities. The main purpose of this unit is to provide an easy-to-use reference summarizing some of the current information on well-established cytokine, growth factore, and chemokine ligands. The information provided is confined largely to alternative names, protein properties, genetic chracteristics, chromosomal localization, cellular expression patters, cellular-tissue targets, stimuli regulating expression, functional properties, expression analysis, and clinical utility.
ER  - 

TY  - JOUR
TI  - Free Communications
JO  - Journal of the European Academy of Dermatology and Venereology
VL  - 11
IS  - s2
SN  - 0926-9959
UR  - https://doi.org/10.1111/j.1468-3083.1998.tb00996.x
DO  - doi:10.1111/j.1468-3083.1998.tb00996.x
SP  - S127
EP  - S185
PY  - 1998
ER  - 

TY  - JOUR
AU  - Sakaguchi, Shimon
TI  - Regulatory T cells in the past and for the future
JO  - European Journal of Immunology
JA  - Eur. J. Immunol.
VL  - 38
IS  - 4
SN  - 0014-2980
UR  - https://doi.org/10.1002/eji.200890012
DO  - doi:10.1002/eji.200890012
SP  - 901
EP  - 937
PY  - 2008
AB  - Abstract No Abtract
ER  - 

TY  - JOUR
TI  - Paper Abstracts
JO  - Journal of the American Geriatrics Society
VL  - 54
IS  - S4
SN  - 0002-8614
UR  - https://doi.org/10.1111/j.1532-5415.2006.00783.x
DO  - doi:10.1111/j.1532-5415.2006.00783.x
SP  - S1
EP  - S203
PY  - 2006
ER  - 

TY  - JOUR
TI  - American College of Clinical Pharmacy
JO  - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
VL  - 10
IS  - 3
SN  - 0277-0008
UR  - https://doi.org/10.1002/j.1875-9114.1990.tb02580.x
DO  - doi:10.1002/j.1875-9114.1990.tb02580.x
SP  - 231
EP  - 257
PY  - 1990
ER  - 

TY  - JOUR
TI  - P02. Posters 2
JO  - Australasian Journal of Dermatology
VL  - 38
IS  - S2
SN  - 0004-8380
UR  - https://doi.org/10.1111/ajd.1997.38.s2.125
DO  - doi:10.1111/ajd.1997.38.s2.125
SP  - 125
EP  - 191
PY  - 1997
ER  - 

TY  - JOUR
TI  - ABSTRACTS—POSTERS
JO  - Alcoholism: Clinical and Experimental Research
VL  - 31
IS  - s2
SN  - 0145-6008
UR  - https://doi.org/10.1111/j.1530-0277.2007.00412.x
DO  - doi:10.1111/j.1530-0277.2007.00412.x
SP  - 9A
EP  - 248A
PY  - 2007
ER  - 
